Targets — browse / sort / filter (view)
Data license: CC BY 4.0 · Data source: apt-scout automated curation pipeline (E. Dohi, NCNP) — values harvested from public databases; raw source stored per target
- id
- UniProt accession (human). Links to uniprot.org.
- gene_symbol
- Gene symbol (e.g. ITGB3).
- protein_name
- Protein name (UniProt).
- tier
- Tier 1 = PDB-anchored; Tier 1.5 = AlphaFold-confident.
- has_structure
- 1 if the target protein has a reported experimental 3D structure (PDB). This is the CORE requirement the aptamer-Kd layer is built around — filter to 1 for the structure-backed set.
- evidence_priority
- DETERMINISTIC, reproducible prioritisation (0-1) computed at build time from real harvested columns: 0.35*experimental-structure(PDB=1 / AlphaFold-only=0.3) + 0.30*Open-Targets-top-disease-score + 0.20*PREDICTED-surface-accessibility(A_surface=1) + 0.15*EV-detection(EV-Map). A transparent ranking AID, not a validation; the surface/EV terms are PREDICTIONS/DETECTIONS, not measured EV-surface exposure. Recomputable exactly from this DB.
- has_activation_state_pdb_pair
- 1 if a curated ACTIVE/INACTIVE PDB pair exists (only 11 targets).
- in_cev_map
- Detected in the EV-Map plasma-EV dataset (Rai & Greening 2025, Nat Cell Biol, 10.1038/s41556-025-01795-7) = 3,422 apt-scout targets (broad detected proteome). The EV-Map CONSERVED EV proteome is 182 proteins (42 non-EV); apt-scout matches 104 of these conserved EV-hallmark proteins as targets by gene (the other 78 are not apt-scout targets). Use the ev_hallmark_targets query for that subset. IMPORTANT: EV-Map detection means the protein is EV CARGO (present in the vesicle) — it does NOT mean surface-exposed. Rai & Greening 2025 run a separate membrane-impermeant biotinylation assay giving a 151-protein SURFACEOME, and show the conserved SDCBP/syntenin is luminal (not surface-accessible). For genuine EV-surface accessibility use that 151-protein set, not EV-Map presence.
- has_known_aptamer
- 1 if PubMed '(gene) AND (aptamer OR SELEX)' returned any hit (KEYWORD co-mention, includes false positives — NOT a verified aptamer). For verified aptamers with Kd, see the Binding-affinities (v_kd) layer.
- opentargets_top_disease_score
- Open Targets association score (0-1).
- aptamer_count_pubmed
- Number of PubMed hits for (this protein) AND (aptamer OR SELEX). Keyword co-occurrence — verify each (many co-mention without a real aptamer).
- aptamer_pmids
- The actual PubMed IDs behind the aptamer evidence — click each to read the paper. This is the source of the 'has aptamer' claim.
- surface_class
- PREDICTED membrane topology (HPA-derived, not a measurement): A_surface = integral/ecto cell-surface (predicted EV-surface accessible); A2_pm_peripheral = plasma-membrane cytoplasmic-leaflet (SRC/LYN/RHOA, predicted not reachable); A_assoc = secreted/corona; B_cargo = luminal cargo; unknown = no HPA localization. Lipid asymmetry can partially flip (PS via scramblase); confirm by protease-protection / intact-EV surface labelling. See v_surface_targets.
1,570 rows where has_known_aptamer = 0, surface_class = "B_cargo" and tier = "Tier 1" sorted by evidence_priority descending
This data as json, CSV (advanced)
| id | gene_symbol | protein_name | tier | evidence_priority ▲ | has_structure | surface_class | pdb_count_total | alphafold_mean_pLDDT | has_cryoEM | has_activation_state_pdb_pair | activation_state_pdb_active | activation_state_pdb_inactive | has_known_aptamer | aptamer_count_pubmed | aptamer_pmids | in_cev_map | opentargets_top_disease_name | opentargets_top_disease_score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P43246 | MSH2 | DNA mismatch repair protein Msh2 | Tier 1 | 0.766 | 1 | B_cargo | 30 | 85.31 | 1 | 0 | 0 | 0 | 1 | Lynch syndrome | 0.8882239051809577 | |||
| P01112 | HRAS | GTPase HRas | Tier 1 | 0.765 | 1 | B_cargo | 100 | 91.94 | 0 | 1 | 5P21 | 4Q21 | 0 | 0 | 1 | Costello syndrome | 0.8839339324666988 | |
| P15289 | ARSA | Arylsulfatase A | Tier 1 | 0.763 | 1 | B_cargo | 10 | 96.12 | 0 | 0 | 0 | 0 | 1 | metachromatic leukodystrophy | 0.8781786404283894 | |||
| O15305 | PMM2 | Phosphomannomutase 2 | Tier 1 | 0.761 | 1 | B_cargo | 7 | 96.44 | 0 | 0 | 0 | 0 | 1 | PMM2-congenital disorder of glycosylation | 0.8687293837006977 | |||
| P08559 | PDHA1 | Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial | Tier 1 | 0.758 | 1 | B_cargo | 9 | 94.5 | 0 | 0 | 0 | 0 | 1 | pyruvate dehydrogenase E1-alpha deficiency | 0.8590861671403908 | |||
| Q96RQ3 | MCCC1 | Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial | Tier 1 | 0.757 | 1 | B_cargo | 14 | 87.62 | 1 | 0 | 0 | 0 | 1 | Isolated 3-methylcrotonyl-CoA carboxylase deficiency | 0.8573370131864518 | |||
| P36507 | MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2 | Tier 1 | 0.757 | 1 | B_cargo | 3 | 81.62 | 0 | 0 | 0 | 0 | 1 | cardiofaciocutaneous syndrome | 0.8571797350022399 | |||
| Q16595 | FXN | Frataxin, mitochondrial | Tier 1 | 0.757 | 1 | B_cargo | 20 | 75.5 | 1 | 0 | 0 | 0 | 1 | Friedreich ataxia | 0.8550760415889643 | |||
| Q04656 | ATP7A | Copper-transporting ATPase 1 | Tier 1 | 0.757 | 1 | B_cargo | 22 | 73.38 | 0 | 0 | 0 | 0 | 1 | Menkes disease | 0.8556218833987248 | |||
| P00966 | ASS1 | Argininosuccinate synthase | Tier 1 | 0.756 | 1 | B_cargo | 1 | 95.5 | 0 | 0 | 0 | 0 | 1 | citrullinemia type I | 0.8547319473775126 | |||
| P11310 | ACADM | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | Tier 1 | 0.756 | 1 | B_cargo | 7 | 93.38 | 1 | 0 | 0 | 0 | 1 | medium chain acyl-CoA dehydrogenase deficiency | 0.8542618568274527 | |||
| P30613 | PKLR | Pyruvate kinase PKLR | Tier 1 | 0.756 | 1 | B_cargo | 58 | 90.69 | 0 | 0 | 0 | 0 | 1 | pyruvate kinase deficiency of red cells | 0.8545857147634045 | |||
| P46100 | ATRX | Transcriptional regulator ATRX | Tier 1 | 0.755 | 1 | B_cargo | 12 | 51.81 | 0 | 0 | 0 | 0 | 1 | alpha thalassemia-X-linked intellectual disability syndrome | 0.8486940552679562 | |||
| P11217 | PYGM | Glycogen phosphorylase, muscle form | Tier 1 | 0.754 | 1 | B_cargo | 1 | 94.31 | 0 | 0 | 0 | 0 | 1 | glycogen storage disease V | 0.8482737151867437 | |||
| Q12756 | KIF1A | Kinesin-like protein KIF1A | Tier 1 | 0.754 | 1 | B_cargo | 21 | 70.5 | 1 | 0 | 0 | 0 | 1 | intellectual disability, autosomal dominant 9 | 0.8481151412193974 | |||
| P51570 | GALK1 | Galactokinase | Tier 1 | 0.753 | 1 | B_cargo | 20 | 97.19 | 0 | 0 | 0 | 0 | 1 | galactokinase deficiency | 0.8442002323363244 | |||
| Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | Tier 1 | 0.753 | 1 | B_cargo | 14 | 94.69 | 1 | 0 | 0 | 0 | 1 | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 0.8437575319886195 | |||
| Q9Y223 | GNE | Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase | Tier 1 | 0.753 | 1 | B_cargo | 5 | 93.12 | 0 | 0 | 0 | 0 | 1 | GNE myopathy | 0.8438241196803116 | |||
| P51649 | ALDH5A1 | Succinate-semialdehyde dehydrogenase, mitochondrial | Tier 1 | 0.753 | 1 | B_cargo | 5 | 91.88 | 0 | 0 | 0 | 0 | 1 | succinic semialdehyde dehydrogenase deficiency | 0.8435061416819137 | |||
| P12694 | BCKDHA | 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial | Tier 1 | 0.753 | 1 | B_cargo | 24 | 91.56 | 0 | 0 | 0 | 0 | 1 | maple syrup urine disease type 1A | 0.8431584865455812 | |||
| Q13144 | EIF2B5 | Translation initiation factor eIF2B subunit epsilon | Tier 1 | 0.752 | 1 | B_cargo | 25 | 78.75 | 1 | 0 | 0 | 0 | 1 | CACH syndrome | 0.8411470079917355 | |||
| P46777 | RPL5 | Large ribosomal subunit protein uL18 | Tier 1 | 0.751 | 1 | B_cargo | 30 | 94.5 | 1 | 0 | 0 | 0 | 1 | Blackfan-Diamond anemia | 0.8352702821155725 | |||
| P16219 | ACADS | Short-chain specific acyl-CoA dehydrogenase, mitochondrial | Tier 1 | 0.751 | 1 | B_cargo | 4 | 93.62 | 1 | 0 | 0 | 0 | 1 | short chain acyl-CoA dehydrogenase deficiency | 0.8352413435265167 | |||
| P07686 | HEXB | Beta-hexosaminidase subunit beta | Tier 1 | 0.751 | 1 | B_cargo | 8 | 92.81 | 0 | 0 | 0 | 0 | 1 | Sandhoff disease | 0.8358490853539441 | |||
| P00367 | GLUD1 | Glutamate dehydrogenase 1, mitochondrial | Tier 1 | 0.751 | 1 | B_cargo | 7 | 90.25 | 1 | 0 | 0 | 0 | 1 | hyperinsulinism-hyperammonemia syndrome | 0.8355052949188112 | |||
| P49768 | PSEN1 | Presenilin-1 | Tier 1 | 0.751 | 1 | B_cargo | 27 | 72.12 | 1 | 0 | 0 | 0 | 1 | Alzheimer disease 3 | 0.8373536811398027 | |||
| Q9BX63 | BRIP1 | Fanconi anemia group J protein | Tier 1 | 0.751 | 1 | B_cargo | 3 | 63.88 | 0 | 0 | 0 | 0 | 1 | Fanconi anemia complementation group J | 0.8380329286110476 | |||
| P63261 | ACTG1 | Actin, cytoplasmic 2 | Tier 1 | 0.75 | 1 | B_cargo | 10 | 95.38 | 1 | 0 | 0 | 0 | 1 | Baraitser-Winter syndrome | 0.834386021888207 | |||
| Q8TB36 | GDAP1 | Ganglioside-induced differentiation-associated protein 1 | Tier 1 | 0.75 | 1 | B_cargo | 8 | 87.31 | 0 | 0 | 0 | 0 | 1 | Autosomal recessive Charcot-Marie-Tooth disease with hoarseness | 0.8335233921018209 | |||
| P06132 | UROD | Uroporphyrinogen decarboxylase | Tier 1 | 0.749 | 1 | B_cargo | 19 | 96.75 | 0 | 0 | 0 | 0 | 1 | Familial porphyria cutanea tarda | 0.8298171209078576 | |||
| P51659 | HSD17B4 | Peroxisomal multifunctional enzyme type 2 | Tier 1 | 0.749 | 1 | B_cargo | 7 | 89.0 | 0 | 0 | 0 | 0 | 1 | d-bifunctional protein deficiency | 0.830341815259975 | |||
| Q9UBK8 | MTRR | Methionine synthase reductase | Tier 1 | 0.749 | 1 | B_cargo | 2 | 85.31 | 0 | 0 | 0 | 0 | 1 | methylcobalamin deficiency type cblE | 0.8288259674381309 | |||
| O14936 | CASK | Peripheral plasma membrane protein CASK | Tier 1 | 0.749 | 1 | B_cargo | 22 | 78.94 | 0 | 0 | 0 | 0 | 1 | X-linked intellectual disability, Najm type | 0.8302355593197244 | |||
| P04075 | ALDOA | Fructose-bisphosphate aldolase A | Tier 1 | 0.748 | 1 | B_cargo | 8 | 96.44 | 0 | 0 | 0 | 0 | 1 | glycogen storage disease due to aldolase A deficiency | 0.826807229393595 | |||
| P32322 | PYCR1 | Pyrroline-5-carboxylate reductase 1, mitochondrial | Tier 1 | 0.748 | 1 | B_cargo | 47 | 89.81 | 0 | 0 | 0 | 0 | 1 | autosomal recessive cutis laxa type 2B | 0.826514119676127 | |||
| P36776 | LONP1 | Lon protease homolog, mitochondrial | Tier 1 | 0.748 | 1 | B_cargo | 29 | 76.69 | 1 | 0 | 0 | 0 | 1 | CODAS syndrome | 0.8273562128539942 | |||
| Q7Z6Z7 | HUWE1 | E3 ubiquitin-protein ligase HUWE1 | Tier 1 | 0.748 | 1 | B_cargo | 19 | 1 | 0 | 0 | 0 | 1 | intellectual disability, X-linked syndromic, Turner type | 0.8251574698433977 | ||||
| P00558 | PGK1 | Phosphoglycerate kinase 1 | Tier 1 | 0.747 | 1 | B_cargo | 30 | 96.38 | 0 | 0 | 0 | 0 | 1 | glycogen storage disease due to phosphoglycerate kinase 1 deficiency | 0.8228898260165487 | |||
| Q71U36 | TUBA1A | Tubulin alpha-1A chain | Tier 1 | 0.747 | 1 | B_cargo | 15 | 91.12 | 1 | 0 | 0 | 0 | 1 | lissencephaly due to TUBA1A mutation | 0.8249848986700001 | |||
| Q9UNE7 | STUB1 | E3 ubiquitin-protein ligase CHIP | Tier 1 | 0.747 | 1 | B_cargo | 21 | 89.31 | 1 | 0 | 0 | 0 | 1 | autosomal recessive spinocerebellar ataxia 16 | 0.8231010720948859 | |||
| P09493 | TPM1 | Tropomyosin alpha-1 chain | Tier 1 | 0.746 | 1 | B_cargo | 14 | 91.62 | 1 | 0 | 0 | 0 | 1 | hypertrophic cardiomyopathy | 0.8201717082603994 | |||
| O43819 | SCO2 | Cytochrome c oxidase assembly factor SCO2 | Tier 1 | 0.746 | 1 | B_cargo | 1 | 83.75 | 0 | 0 | 0 | 0 | 1 | cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1 | 0.8204831517684852 | |||
| Q8IYB7 | DIS3L2 | DIS3-like exonuclease 2 | Tier 1 | 0.746 | 1 | B_cargo | 4 | 82.69 | 1 | 0 | 0 | 0 | 1 | Perlman syndrome | 0.8206937660793029 | |||
| Q8TEQ6 | GEMIN5 | Gem-associated protein 5 | Tier 1 | 0.746 | 1 | B_cargo | 16 | 78.94 | 1 | 0 | 0 | 0 | 1 | neurodevelopmental disorder with cerebellar atrophy and motor dysfunction | 0.8184088962562686 | |||
| P09467 | FBP1 | Fructose-1,6-bisphosphatase 1 | Tier 1 | 0.745 | 1 | B_cargo | 51 | 94.31 | 0 | 0 | 0 | 0 | 1 | fructose-1,6-bisphosphatase deficiency | 0.8178590536523854 | |||
| P18077 | RPL35A | Large ribosomal subunit protein eL33 | Tier 1 | 0.744 | 1 | B_cargo | 30 | 95.56 | 1 | 0 | 0 | 0 | 1 | Blackfan-Diamond anemia | 0.8140112443681048 | |||
| P50440 | GATM | Glycine amidinotransferase, mitochondrial | Tier 1 | 0.744 | 1 | B_cargo | 11 | 89.62 | 0 | 0 | 0 | 0 | 1 | AGAT deficiency | 0.8130880750586561 | |||
| P17900 | GM2A | Ganglioside GM2 activator | Tier 1 | 0.744 | 1 | B_cargo | 8 | 88.94 | 0 | 0 | 0 | 0 | 1 | GM2-gangliosidosis, AB variant | 0.8134379375819221 | |||
| Q13825 | AUH | Methylglutaconyl-CoA hydratase, mitochondrial | Tier 1 | 0.744 | 1 | B_cargo | 3 | 85.69 | 0 | 0 | 0 | 0 | 1 | 3-methylglutaconic aciduria type 1 | 0.8135711454915439 | |||
| Q9UI10 | EIF2B4 | Translation initiation factor eIF2B subunit delta | Tier 1 | 0.744 | 1 | B_cargo | 25 | 76.5 | 1 | 0 | 0 | 0 | 1 | CACH syndrome | 0.8146710778484454 |
Advanced export
JSON shape: default, array, newline-delimited
CREATE VIEW v_targets AS
SELECT f.id, n.gene_symbol, n.protein_name, tg.tier,
-- evidence_priority: DETERMINISTIC, reproducible from real DB columns (no LLM).
-- Transparent weights over harvested evidence: structure 0.35, disease importance
-- 0.30 (Open Targets top-disease score), PREDICTED surface accessibility 0.20,
-- EV detection 0.15. A heuristic ranking aid, not a validation; surface/EV terms
-- are predictions/detections, NOT measured EV-surface exposure.
ROUND(
0.35*(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1.0
WHEN CAST(COALESCE(NULLIF(f.alphafold_mean_pLDDT,''),'0') AS REAL)>0 THEN 0.3 ELSE 0.0 END)
+ 0.30*MIN(CAST(COALESCE(NULLIF(f.opentargets_top_disease_score,''),'0') AS REAL), 1.0)
+ 0.20*(CASE sc.surface_class WHEN 'A_surface' THEN 1.0 WHEN 'A_assoc' THEN 0.5 WHEN 'A2_pm_peripheral' THEN 0.2 ELSE 0.0 END)
+ 0.15*(CASE WHEN CAST(COALESCE(f.in_cev_map,0) AS INTEGER)=1 THEN 1.0 ELSE 0.0 END)
, 3) AS evidence_priority,
(CASE WHEN CAST(COALESCE(f.pdb_count_total,'0') AS INTEGER)>0 THEN 1 ELSE 0 END) AS has_structure,
sc.surface_class,
f.pdb_count_total, f.alphafold_mean_pLDDT, f.has_cryoEM,
f.has_activation_state_pdb_pair, f.activation_state_pdb_active, f.activation_state_pdb_inactive,
f.has_known_aptamer, f.aptamer_count_pubmed, ap.aptamer_pmids,
f.in_cev_map, f.opentargets_top_disease_name, f.opentargets_top_disease_score
FROM v_target_full f
LEFT JOIN target_names n ON n.target_id=f.id
LEFT JOIN targets tg ON tg.id=f.id
LEFT JOIN target_aptamer_pmids ap ON ap.target_id=f.id
LEFT JOIN membrane_surface_class sc ON sc.target_id=f.id;